Your browser doesn't support javascript.
loading
Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia.
Mohammed, Hussein; Sime, Heven; Hailgiorgis, Henok; Chernet, Melkie; Alebachew, Mihreteab; Solomon, Hiwot; Assefa, Gudissa; Haile, Mebrahtom; Girma, Samuel; Bekele, Worku; Tasew, Geremew; Gidey, Bokretsion; Commons, Robert J; Assefa, Ashenafi.
Afiliación
  • Mohammed H; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia. hussein_ehnri@yahoo.com.
  • Sime H; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Hailgiorgis H; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Chernet M; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Alebachew M; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
  • Solomon H; National Malaria Elimination Program, Ministry of Health, Addis Ababa, Ethiopia.
  • Assefa G; National Malaria Elimination Program, Ministry of Health, Addis Ababa, Ethiopia.
  • Haile M; National Malaria Elimination Program, Ministry of Health, Addis Ababa, Ethiopia.
  • Girma S; USAID, Addis Ababa, Ethiopia.
  • Bekele W; World Health Organization, Addis Ababa, Ethiopia.
  • Tasew G; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Gidey B; Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Commons RJ; Global Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • Assefa A; General and Subspecialty Medicine, Grampians Health, Ballarat, Australia.
Malar J ; 21(1): 401, 2022 Dec 31.
Article en En | MEDLINE | ID: mdl-36587210
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 / 3_ND Problema de salud: 11_delivery_arrangements / 2_cobertura_universal / 2_enfermedades_transmissibles / 3_malaria / 3_neglected_diseases Asunto principal: Malaria Vivax / Malaria Falciparum / Antimaláricos Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2022 Tipo del documento: Article País de afiliación: Etiopia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 / 3_ND Problema de salud: 11_delivery_arrangements / 2_cobertura_universal / 2_enfermedades_transmissibles / 3_malaria / 3_neglected_diseases Asunto principal: Malaria Vivax / Malaria Falciparum / Antimaláricos Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2022 Tipo del documento: Article País de afiliación: Etiopia